Tuesday, July 21, 2015 4:40:29 PM
Since there is a significant movement today, here is a quick update. As I have said previously, this stock is getting attention from significant traders, and therefore, volatility should be expected. TNXP closed very strong today with ‘seeking alpha’ articles.
http://seekingalpha.com/article/3339185-tonix-its-blockbuster-headache-remedy-two-2015-catalysts-and-two-post-offering-valuations
http://seekingalpha.com/article/3338995-insider-buying-in-tonix-should-investors-follow-suit
For those, who missed my previous analysis for this stock, here is the link:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=115498860
General Updates:
a) The bulls continue to dominate on 30 minutes and hourly chart. Daily chart confirms trend reversal in progress. Few indicators for daily chart support this.
b) This stock likes being in overbought/oversold levels for extended time as we have noted from past. I am not much worried looking at these indicators at this point.
c) Intraday chart is of prominence for this stock, to identify buy and sell points. What we saw today is a new trend line formation, when price broke 9.32 levels. I have drawn the new trend lines ( in black in 5 min chart ) below. We do not know how long this trend line would continue, but TNXP is known for steep trend lines running into days.
d) Immediate support points would be 8.75-8.85 area,9.35-9.45 and lower trend line.
e) Following would be a nice resistance area for this stock – 9.8ish zone.
f) The daily chart has got more room to run without consolidation, I am hoping this to go above 10$ in coming days, and 12$+ in few weeks/months. If there is pullback, we could expect to see the pullback within trend line. The breach of trend line with pps dropping below lower trendline should be considered bearish. In my opinion, we are few days ahead of this scenario.
I continue to buy/sell TNXP following the trend lines and other indicators. My analysis shouldn't be taken as is, since i could be completely wrong.Trade smart, buy low and sell high. Do your due diligence.
Posting 5 min chart and daily chart today.
Thanks
blackdeath
Recent TNXP News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/23/2024 09:09:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:08:50 AM
- Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) • GlobeNewswire Inc. • 09/23/2024 11:00:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/20/2024 09:03:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 11:05:26 AM
- Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:23:27 AM
- Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/13/2024 09:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 11:05:24 AM
- Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations • GlobeNewswire Inc. • 09/10/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 11:07:15 AM
- Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta • GlobeNewswire Inc. • 09/09/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 09:17:58 PM
- Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek • GlobeNewswire Inc. • 09/06/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 09:08:17 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/30/2024 09:04:45 PM
- Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS) • GlobeNewswire Inc. • 08/29/2024 11:00:00 AM
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS) • GlobeNewswire Inc. • 08/28/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 11:05:17 AM
- Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801 • GlobeNewswire Inc. • 08/26/2024 11:00:00 AM
- Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS) • GlobeNewswire Inc. • 08/21/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 11:05:23 AM
- Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication • GlobeNewswire Inc. • 08/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 10:05:58 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM